Articles dans des revues avec comité de lecture (253)
  1. 131. Castañé, A., Célérier, E., Martín, M., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2006). Development and expression of neuropathic pain in CB1 knockout mice. Neuropharmacology, 50(1), 111-122. doi:10.1016/j.neuropharm.2005.07.022
  2. 132. Teixeira-Clerc, F., Julien, B., Grenard, P., Tran Van Nhieu, J., Deveaux, V., Li, L., Serriere-Lanneau, V., Ledent, C., Mallat, A., & Lotersztajn, S. (2006). Les antagonistes du récepteur CB1 des cannabinoïdes : une nouvelle approche pour le traitement de la fibrose hépatique. MS. Médecine sciences, 22(8-9), 683-685.
  3. 133. Laurent, P., Becker, J., Valverde, O., Ledent, C., de Kerchove d'Exaerde, A., Schiffmann, S. N., Maldonado, R., Vassart, G., & Parmentier, M. (2005). The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10. Nature neuroscience, 8(12), 1735-1741. doi:10.1038/nn1585
  4. 134. Jardinaud, F., Crété, D., Canestrelli, C., Ledent, C., Roques, B. P., & Noble, F. (2005). CB1 receptor knockout mice show similar behavioral modifications to wild-type mice when enkephalin catabolism is inhibited. Brain research, 1063(1), 77-83. doi:10.1016/j.brainres.2005.09.015
  5. 135. Urigüen, L., Berrendero, F., Ledent, C., Maldonado, R., & Manzanares, J. (2005). Kappa- and delta-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice. European journal of neuroscience, 22(8), 2106-2110. doi:10.1111/j.1460-9568.2005.04372.x
  6. 136. El Yacoubi, M., Ledent, C., Parmentier, M., Costentin, J., & Vaugeois, J.-M. (2005). Reduced appetite for caffeine in adenosine A(2A) receptor knockout mice. European journal of pharmacology, 519(3), 290-291. doi:10.1016/j.ejphar.2005.07.022
  7. 137. Soria, G., Mendizábal, V., Touriño, C., Robledo, P., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2005). Lack of CB1 cannabinoid receptor impairs cocaine self-administration. Biological psychiatry, 30(9), 1670-1680. doi:10.1038/sj.npp.1300707
  8. 138. Haller, J., Szirmai, M., Varga, B., Ledent, C., & Freund, T. F. (2005). Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia. Behavioural pharmacology, 16(5-6), 415-422.
  9. 139. Bodor, Á. L., Katona, I., Nyíri, G., Mackie, K., Ledent, C., Hájos, N., & Freund, T. F. (2005). Endocannabinoid signaling in rat somatosensory cortex: Laminar differences and involvement of specific interneuron types. The Journal of neuroscience, 25(29), 6845-6856. doi:10.1523/JNEUROSCI.0442-05.2005
  10. 140. Depaepe, V., Suarez Gonzalez, N., Dufour, A., Passante, L., Gorski, J. A., Jones, K. R., Ledent, C., & Vanderhaeghen, P. (2005). Ephrin signalling controls brain size by regulating apoptosis of neural progenitors. Nature (London), 435(7046), 1244-1250. doi:10.1038/nature03651
  11. 141. Ledent, C., Demeestere, I., Blum, D., Petermans, J., Hämäläinen, T., Smits, G., & Vassart, G. (2005). Premature ovarian aging in mice deficient for Gpr3. Proceedings of the National Academy of Sciences of the United States of America, 102(25), 8922-8926. doi:10.1073/pnas.0503840102
  12. 142. Ghanem, E., Lövdahl, C., Daré, E., Ledent, C., Fredholm, B. B., Boeynaems, J.-M., Van Driessche, W., & Beauwens, R. (2005). Luminal adenosine stimulates chloride secretion through A1 receptor in mouse jejunum. American journal of physiology: Gastrointestinal and liver physiology, 288(5), G972-G977. doi:10.1152/ajpgi.00346.2004
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Suivant >>